AGIO
AGIO
US00847X1046
Agios Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.9B EUR
2.21B EUR
2.01B EUR
1.59B EUR
Enterprise Value
1.32B EUR
2.14B EUR
1.93B EUR
1.54B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-7.91x
--
--
--
Price to Sales
19.31x
22.49x
30.39x
35.12x
Price to Book
1.85x
2.16x
0.83x
1.33x
EV/Revenue
13.42x
21.8x
29.22x
34.04x
EV/EBITDA
-2.91x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-14.46%
-17.64%
-19.66%
-17.29%
ende